References
- Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nature Immunol 2002; 2: 647–55
- Shewry PR, Tatham AS, Kasarda DD. Cereal proteins and coeliac disease. Coeliac disease, MN Marsh. Blackwell Scientific Publications, Oxford 1992; 305–48
- Kim SI, Charbonnier L, Mossé J. Heterogeneity of avenin, the oat prolamin. Fractionation, molecular weight and amino acid composition. Biochim Biophys Acta 1978; 537: 22–30
- Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly C, et al. Absence of oats toxicity in adult coeliac disease. Br Med J 1996; 313: 1300–1
- Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma V-M, Järvinen RMK, Uusitupa MIJ, et al. A comparison of diets with and without oats in adults with coeliac disease. N Engl J Med 1995; 333: 1033–7
- Janatuinen EK, Kemppainen TA, Pikkarainen PH, Holm KH, Kosma V-M, Uusitupa MI, et al. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000; 46: 327–31
- Janatuinen EK, Kemppainen TA, Julkunen RJK, Kosma V-M, Mäki M, Heikkinen M, et al. No harm from five-year ingestion of oats in coeliac disease. Gut 2002; 50: 332–5
- Storsrud S, Olsson M, Arvidsson Lenner R, Nilsson L, Kilander A. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr 2003; 57: 163–9
- Kilmartin C, Lynch S, Abuzakouk M, Wieser H, Feighery C. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut 2003; 52: 47–52
- Picarelli A, Di Tola M, Sabbatella L, Gabrielli F, Di Cello T, Anania MC, et al. Immunologic evidence of no harmful effect of oats in celiac disease. Am J Clin Nutr 2001; 74: 137–40
- Lundin KEA, Nilsen EM, Scott HG, Loberg EM, Gjoen A, Bratlie J, et al. Oats induced villous atrophy in coeliac disease. Gut 2003; 52: 1649–52
- Hoffenberg EJ, Haas J, Drescher A, Barnburst R, Osberg I, Bao F, et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr 2000; 137: 361–6
- Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky E, Jansson G, et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004; 53: 649–54
- Hollén E, Högberg L, Stenhammar L, Fälth-Magnusson K, Magnusson KE. Antibodies to oat prolamines (avenins) in children with coeliac disease. Scand J Gastroenterol 2003; 38: 742–6
- Verdon CP, Burton BA, Prior RL. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502–8
- Sundqvist T, Laurin P, Fälth-Magnusson K, Magnusson KE, Stenhammar L. Significantly increased levels of nitric oxide products in urine of children with coeliac disease. J Pediatr Gastroenterol Nutr 1998; 27: 196–8
- Holmgren Peterson K, Fälth-Magnusson K, Magnusson KE, Stenhammar L, Sundqvist T. Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand J Gastroenterol 1998; 33: 939–43
- Ciclitira P. Recent advances in coeliac disease. Clin Med 2003; 3: 166–9
- Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993; 54: 229–70
- Burgin-Wolff A, Gaze H, Hadziselimovic F, Huber H, Lentze MJ, Nussle D, et al. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991; 66: 941–7
- Fälth-Magnusson K, Jansson G, Stenhammar L, Magnuson K-E. Serum food antibodies analyzed by enzyme-linked immunosorbent assay (ELISA) and diffusion-in-gel (DIG)-ELISA methods in children with and without celiac disease. J Pediatr Gastroenterol Nutr 1994; 18: 56–62
- Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinnelli A, Castagnani R, et al. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993; 34: 1515–9
- Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, et al. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004; 1: 84–92